Wegovy is a medication used to treat obesity in adults. It contains semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. Wegovy is different from other medications because it is a once-weekly injection, while other weight loss medications are taken orally or daily. The active ingredient in Wegovy, semaglutide, is also found in Ozempic, which is used to treat type 2 diabetes. However, the dosage of semaglutide in Wegovy is higher than that in Ozempic. According to [2], Wegovy has been shown to be more effective than other weight loss medications, including Ozempic and Mounjaro. In clinical trials, patients taking Wegovy lost more weight than those taking other medications. Additionally, Wegovy has been found to improve other health markers, such as blood sugar levels and blood pressure. However, like all medications, Wegovy can have side effects, including nausea, diarrhea, and vomiting. It is important to talk to a healthcare provider before starting any new medication.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/WEGOVY
[2] https://www.verywellhealth.com/ozempic-vs-wegovy-vs-mounjaro-7368829
[3] https://www.uchealth.org/today/wegovy-vs-ozempic-the-truth-about-new-weight-loss-drugs/